Validation of a Care Pathway for the Use of Faecal Calprotectin in Monitoring Patients with Crohn’s Disease


The team around James Turvill has proposed a highly useful care pathway for monitoring Crohn’s Disease patients. The care pathway offers a very high positive predictive value for the detection of patients with potential flare-ups of their disease while safely identifying those patients in which the therapy could be stepped down.

Turvill J, Rook L, Rawle M, et al. Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn’s disease. Frontline Gastroenterology Published Online First: 30 January 2017. doi: 10.1136/flgastro-2016-100780.